XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series A and B Convertible Preferred Stock
Preferred Stock
Common stock
At-the-market sales
Common stock
Series A Convertible Preferred Stock
Common stock
Series B Convertible Preferred Stock
Common stock
Additional Paid in Capital.
At-the-market sales
Additional Paid in Capital.
Series A Convertible Preferred Stock
Additional Paid in Capital.
Series B Convertible Preferred Stock
Additional Paid in Capital.
Accumulated Other Comprehensive Income
Accumulated Deficit
At-the-market sales
Series A and B Convertible Preferred Stock
Total
Balance at Dec. 31, 2020                       $ 361,548 $ 3 $ (312,223)     $ 49,328
Balance (in shares) at Dec. 31, 2020               2,189,094                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       742         742
Issuance of common stock                 $ 960           $ 960    
Issuance of common stock (in shares)         13,023                        
Issuance of common stock upon exercise of options                       75         75
Issuance of common stock upon exercise of options (in shares)               3,160                  
Vesting of RSUs (in shares)               1,316                  
Warrants issued in connection with long-term debt                       1,080         1,080
Unrealized net gain on marketable securities                         (3)       (3)
Net loss                           (17,128)     (17,128)
Balance at Mar. 31, 2021                       364,405   (329,351)     35,054
Balance (in shares) at Mar. 31, 2021               2,206,593                  
Balance at Dec. 31, 2020                       361,548 $ 3 (312,223)     49,328
Balance (in shares) at Dec. 31, 2020               2,189,094                  
Increase (decrease) in stockholders' equity                                  
Unrealized net gain on marketable securities                                 (3)
Net loss                                 (51,537)
Balance at Sep. 30, 2021                       374,440   (363,760)     10,680
Balance (in shares) at Sep. 30, 2021               2,368,235                  
Balance at Mar. 31, 2021                       364,405   (329,351)     35,054
Balance (in shares) at Mar. 31, 2021               2,206,593                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       843         843
Issuance of common stock                 6,349           6,349    
Issuance of common stock (in shares)         114,826                        
Vesting of RSUs (in shares)               1,786                  
Net loss                           (17,637)     (17,637)
Balance at Jun. 30, 2021                       371,597   (346,988)     24,609
Balance (in shares) at Jun. 30, 2021               2,323,205                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       887         887
Issuance of common stock                 1,956           1,956    
Issuance of common stock (in shares)         45,030                        
Net loss                           (16,772)     (16,772)
Balance at Sep. 30, 2021                       374,440   (363,760)     10,680
Balance (in shares) at Sep. 30, 2021               2,368,235                  
Balance at Dec. 31, 2021                       396,388   (387,117)     9,271
Balance (in shares) at Dec. 31, 2021               3,034,901                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       764         764
Issuance of common stock                 348           348    
Issuance of common stock (in shares)         25,623                        
Registered direct financing costs, inclusive of warrants       $ (965)               244         (721)
Conversion of convertible preferred stock $ (897)   $ 4,850             $ 897           $ 4,850  
Conversion of convertible preferred stock (in shares) (2,425)   4,850     303,125                      
Vesting of RSUs (in shares)               1,773                  
Warrants issued in connection with registered direct offering       (2,101)               2,101          
Net loss                           (11,769)     (11,769)
Balance at Mar. 31, 2022       $ 887               400,742   (398,886)     2,743
Balance (in shares) at Mar. 31, 2022       2,425       3,365,422                  
Balance at Dec. 31, 2021                       396,388   (387,117)     9,271
Balance (in shares) at Dec. 31, 2021               3,034,901                  
Increase (decrease) in stockholders' equity                                  
Net loss                                 (43,652)
Balance at Sep. 30, 2022               $ 4       437,027   (430,771)     6,260
Balance (in shares) at Sep. 30, 2022               39,026,823                  
Balance at Mar. 31, 2022       $ 887               400,742   (398,886)     2,743
Balance (in shares) at Mar. 31, 2022       2,425       3,365,422                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       669         669
Fractional shares retired as a result of reverse split               (10)                  
Issuance of common stock         $ 1       12,225           12,226    
Issuance of common stock (in shares)         8,687,502                        
Conversion of convertible preferred stock   $ (887)                 $ 887            
Conversion of convertible preferred stock (in shares)   (2,425)         303,125                    
Vesting of RSUs (in shares)               4,118                  
Net loss                           (12,219)     (12,219)
Balance at Jun. 30, 2022               $ 1       414,523   (411,105)     3,419
Balance (in shares) at Jun. 30, 2022               12,360,157                  
Increase (decrease) in stockholders' equity                                  
Share-based compensation - stock options and RSUs                       536         536
Issuance of common stock         $ 3       $ 21,968           $ 21,971    
Issuance of common stock (in shares)         26,666,666                        
Net loss                           (19,666)     (19,666)
Balance at Sep. 30, 2022               $ 4       $ 437,027   $ (430,771)     $ 6,260
Balance (in shares) at Sep. 30, 2022               39,026,823